ro 31-8220 has been researched along with Reperfusion Injury in 1 studies
Ro 31-8220: a protein kinase C inhibitor
Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, C | 1 |
| Xu, Y | 1 |
| Huang, Y | 2 |
1 other study available for ro 31-8220 and Reperfusion Injury
| Article | Year |
|---|---|
Effects of erythropoietin and methylprednisolone on AQP4 expression in astrocytes.
Topics: Animals; Animals, Newborn; Aquaporin 4; Astrocytes; Cell Hypoxia; Cell Survival; Erythropoietin; Fem | 2017 |